T. Rowe Price Associates’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-102,308
Closed -$123K – 2942
2023
Q2
$123K Sell
102,308
-9,100
-8% -$11.2K ﹤0.01% 2656
2023
Q1
$170K Buy
111,408
+3,276
+3% +$12.3K ﹤0.01% 2565
2022
Q4
$408K Sell
108,132
-5,549
-5% -$29.3K ﹤0.01% 2230
2022
Q3
$567K Buy
113,681
+30,386
+36% +$170K ﹤0.01% 2062
2022
Q2
$386K Buy
83,295
+25,595
+44% +$157K ﹤0.01% 2332
2022
Q1
$434K Buy
57,700
+26,000
+82% +$211K ﹤0.01% 2399
2021
Q4
$280K Buy
+31,700
New +$325K ﹤0.01% 2615

Other funds holding PTRA

T. Rowe Price Associates's PTRA Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 102,308 shares — an estimated $123K sold.

T. Rowe Price Associates first reported a position in PTRA in Q4 2021 and held it in 7 quarters. The position peaked at $567K in Q3 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 102,308 Proterra Inc. Common Stock shares in Q3 2023, an estimated $123K.
  • T. Rowe Price Associates first reported a position in Proterra Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • T. Rowe Price Associates's Proterra Inc. Common Stock position peaked at $567K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.